Skip to contentAKKARAJU SRINIVAS — SEATTLE GENETICS INC /WA insider: 552 transactions · InsiderLensAKKARAJU SRINIVAS
- 10% owner at Scholar Rock Holding Corp · on record since Oct 18, 2023
- Director at SEATTLE GENETICS INC /WA · on record since May 23, 2006
- 10% owner at CARGO Therapeutics, Inc. · on record since Nov 16, 2023
- Director at vTv Therapeutics Inc. · on record since Feb 29, 2024
- 10% owner at vTv Therapeutics Inc. · on record since Feb 29, 2024
- Director at ALUMIS INC. · on record since Jun 27, 2024
- Director at PHARMOS CORP · on record since Nov 6, 2006
- Director at Kalaris Therapeutics, Inc. · on record since May 22, 2026
- 10% owner at Kalaris Therapeutics, Inc. · on record since May 22, 2026
- 10% owner at Neurogene Inc. · on record since Nov 27, 2024
- Director at BARRIER THERAPEUTICS INC · on record since Jun 8, 2007
- 10% owner at NOVACEA INC · on record since Feb 6, 2009
- Director at TRIMERIS INC · on record since Dec 21, 2011
- 10% owner at WORLD HEART CORP · on record since Jan 28, 2010
- 10% owner at GRAPHITE CORP · on record since Jun 24, 2021
- Member of 10% owner group at ICAGEN INC · on record since Jul 29, 2011
- Former 10% Beneficial Owner at NOVACEA INC · on record since Jul 20, 2011
- Former Director at TRIMERIS INC · on record since Jun 28, 2012
- 10% owner at Durata Therapeutics, Inc. · on record since Jul 26, 2012
- 10% owner at MARSHALL EDWARDS INC · on record since Dec 28, 2012
- Director at INTERCEPT PHARMACEUTICALS INC · on record since Nov 20, 2012
- Director at EYETECH PHARMACEUTICALS INC · on record since Jan 29, 2004
- Director at Versartis, Inc. · on record since Mar 28, 2014
- 10% owner at Versartis, Inc. · on record since Mar 28, 2014
- Director at ZS Pharma, Inc. · on record since Jun 24, 2014
- Director at Scholar Rock Holding Corp · on record since Jun 8, 2026
- 10% owner at ALIMERA SCIENCES INC · on record since Sep 15, 2014
- 10% owner at Ocugen, Inc. · on record since Dec 10, 2014
- 10% owner at One e Commerce CORP · on record since Jan 29, 2015
- Director at Lifeline Systems, Inc. · on record since May 6, 2015
- 10% owner at Lifeline Systems, Inc. · on record since May 6, 2015
- 10% owner at Mirna Therapeutics, Inc. · on record since Sep 30, 2015
- 10% owner at Aclaris Therapeutics, Inc. · on record since Oct 13, 2015
- Director at Syros Pharmaceuticals, Inc. · on record since Jun 12, 2017
- Director at Principia Biopharma Inc. · on record since Sep 20, 2018
- Former Director at Versartis, Inc. · on record since Apr 9, 2020
- Director at Jiya Acquisition Corp. · on record since Nov 25, 2020
- 10% owner at Jiya Acquisition Corp. · on record since Nov 25, 2020
- Director at ADURO BIOTECH, INC. · on record since Oct 7, 2020
- Director at Mineralys Therapeutics, Inc. · on record since Feb 16, 2023
- 10% owner at Mineralys Therapeutics, Inc. · on record since Feb 16, 2023
Insider trading activity of AKKARAJU SRINIVAS
- Transactions on record
- 552
- since Feb 6, 2004
- Open-market buys
- 87
- $233.2M
- Open-market sells
- 120
- $106.5M
- Companies traded
- 21
- last filing Jul 2, 2026
Figures computed from official regulatory filings — methodology.
Companies where AKKARAJU SRINIVAS has traded
- ALUMIS INC.27 tx · $45.5M · Jul 2, 2026
- vTv Therapeutics Inc.14 tx · $14.2M · Jun 29, 2026
- Scholar Rock Holding Corp23 tx · $77.2M · Jun 8, 2026
- Kalaris Therapeutics, Inc.8 tx · $16.2M · Jun 4, 2026
- Mineralys Therapeutics, Inc.10 tx · $45.6M · Feb 20, 2026
- Neurogene Inc.4 tx · $1.3M · Nov 27, 2024
- Syros Pharmaceuticals, Inc.38 tx · $14.8M · Sep 18, 2024
- CARGO Therapeutics, Inc.5 tx · $10M · Nov 16, 2023
- INTERCEPT PHARMACEUTICALS INC87 tx · $67.4M · Nov 13, 2023
Track record of AKKARAJU SRINIVAS
Statistical track record
Free- Open-market buys
- 94
- Last buy
- May 20, 2026
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of AKKARAJU SRINIVAS
Co-insiders of AKKARAJU SRINIVAS
- HEALY JAMESAclaris Therapeutics, Inc. +8
- POWELL MICHAELAclaris Therapeutics, Inc. +8
- Mehra AnandAclaris Therapeutics, Inc. +7
- Samsara BioCapital, L.P.CARGO Therapeutics, Inc. +6
- Sofinnova Management VIII, L.L.C.Aclaris Therapeutics, Inc. +6
- Sofinnova Venture Partners VIII, L.P.Aclaris Therapeutics, Inc. +6
- Samsara BioCapital GP, LLCCARGO Therapeutics, Inc. +5
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
15 tx · $28.6M · Aug 11, 2023
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jul 2, 2026 | AwardD | 15,528 | 0.00 USD | — | SEC |
| Jul 2, 2026 | Award | 3,553 | 0.00 USD | — | SEC |
| Jun 29, 2026 | AwardD | 6,000 | 35.08 USD | — | SEC |
| Jun 8, 2026 | AwardD | 4,310 | 0.00 USD | $0 | SEC |
| Jun 8, 2026 | Award | 6,839 | 0.00 USD | $0 | SEC |
| Jun 4, 2026 | AwardD | 9,000 | 0.00 USD | $0 | SEC |
| May 22, 2026 | Buy | 244,300 | 4.83 USD | $1.2M | SEC |
| May 22, 2026 | Other | -66,906 | 0.00 USD | $0 | SEC |
| May 22, 2026 | Other | 4,471 | 0.00 USD | $0 | SEC |
| May 22, 2026 | Other | 14,937 | 0.00 USD | $0 | SEC |
| Feb 20, 2026 | AwardD | 8,300 | 0.00 USD | $0 | SEC |
| Feb 20, 2026 | Award | 6,200 | 0.00 USD | $0 | SEC |
| Jan 13, 2026 | Buy | 588,235 | 17.00 USD | $10M | SEC |
| Dec 22, 2025 | Award | 1,500,000 | 10.00 USD | $15M | SEC |
| Dec 16, 2025 | Buy | 4,403 | 40.97 USD | $180.4K | SEC |
| Dec 16, 2025 | Buy | 12,796 | 39.31 USD | $503K | SEC |
| Dec 16, 2025 | Other | 1,064,804 | 7.35 USD | $7.8M | SEC |
| Dec 16, 2025 | OtherD | -1,064,804 | 0.00 USD | $0 | SEC |
| Dec 16, 2025 | Buy | 12,400 | 40.18 USD | $498.2K | SEC |
| Dec 9, 2025 | Buy | 64,969 | 8.95 USD | $581.5K | SEC |
| Dec 9, 2025 | Buy | 51,380 | 10.73 USD | $551.3K | SEC |
| Dec 9, 2025 | Buy | 70,028 | 10.01 USD | $701K | SEC |
| Dec 4, 2025 | Buy | 96,000 | 7.55 USD | $724.8K | SEC |
| Dec 4, 2025 | Buy | 66,027 | 8.18 USD | $540.1K | SEC |
| Dec 4, 2025 | Buy | 100,000 | 7.75 USD | $775K | SEC |